Subscribe
AI
2 min read

QuantHealth raises $45M to simulate clinical trials before patients enroll

QuantHealth raised a $45M Series B led by Qumra Capital to grow its AI platform that simulates clinical trials before patients enroll. It says it has simulated 600+ trials with up to 90% predictive accuracy.

Illustration of a teal and cream capsule breaking open into a network of nodes, medical crosses and data charts
Illustration of a teal and cream capsule breaking open into a network of nodes, medical crosses and data charts

QuantHealth, a Tel Aviv startup, has raised $45 million in Series B funding to grow its clinical trial simulation platform. Qumra Capital led the round. CEO and co-founder Orr Inbar told Fierce Healthcare the company has raised about $70 million to date; it was founded in 2020.

Scientists running a virtual clinical trial simulation before patients enroll

The aim is to test a trial in software before a single patient is recruited. QuantHealth's platform lets biopharma teams test protocols, refine inclusion and exclusion criteria, and model commercial outcomes in silico, HIT Consultant reports. QuantHealth says it partners with 12 of the world's top 20 pharmaceutical companies. For other ways AI is used in drug development and hospitals today, see our guide to AI in healthcare.

Why it matters: roughly 90% of drugs that enter clinical trials never make it to market, a failure rate that costs the industry billions of dollars every year, according to MedCity News. QuantHealth says simulating a trial first lets sponsors evaluate clinical and commercial decisions before they enroll patients or commit capital.

To date, QuantHealth says it has simulated more than 600 clinical trials across 30 indications, with up to 90% predictive accuracy. It plans to expand to more than 40 indications in its core areas: oncology, cardiometabolic disease and inflammation.

The company says the new capital will go to next-generation AI models, deeper scientific validation, expanded datasets and therapeutic coverage, a larger team, and products that reach from trial design to go-to-market positioning. Pitango HealthTech, Sanofi Ventures, Artofin Venture Capital Fund, Bertelsmann Healthcare Investments, GC Ventures, NewHealth Ventures, Shoni Top Ventures and Esplanade Ventures also took part in the round.

Sources

AIHealthcareStartupsFunding